Stenberg VY, Liukaityte R, Kristiansen SK, Wangen-Riise R, Kleinauskas A, Dunne V, Juzeniene A(2025) Cytotoxicity and cell cycle changes in prostate cancer cells with differing PSMA expression and p53 status after treatment with PSMA-targeting radioligand [212Pb]Pb-AB001 Sci Rep(in press) DOI 10.1038/s41598-025-29785-7, PubMed 41318731
Ramberg H, Zucknick M, Barletta F, Davik P, Nybøen Å, Eri LM, Sivanesan S, Hole KH, Hompland T, Prestbakk SO, Gandaglia G, Bathen TF, Briganti A, Berge V, Tasken KA(2025) Development and evaluation of a lymph node invasion risk prediction model in intermediate- and high-risk prostate cancer patients Acta Oncol, 64, 1446-1454 DOI 10.2340/1651-226X.2025.43970, PubMed 41123130
Kalamara A, Stamatelatos IE, Stefanopoulos KL, Kalef-Ezra JA, Georgakilas AG, Stewart RD, Rangos V, Knudsen KD, Helgesen G, Trtik P, Mannes D, Hovind J, Kaestner A, Strobl M, Vinš M, Klupák V, Rabochová M, Šoltés J, Milčák J, Grigalavicius M, Theodossiou TA(2025) A dosimetric and biological model for neutron capture therapy (NCT) experiments Appl Radiat Isot, 226, 112233 DOI 10.1016/j.apradiso.2025.112233, PubMed 41086490
